12.1.10
Asthma in Pregnancy
Malawi Standard Treatment Guidelines, 6th Edition, 2023. Chapter 12, Sexual and Reproductive Health.
Clinical Description
Reversible airway inflammation and bronchoconstriction.
Signs and Symptoms
- Asthma is unpredictable in pregnancy: 1/3 of women report improvement, 1/3 remain the same, and 1/3 worsen.
- Trigger (often viral), chest tightness, shortness of breath, cough, wheezing, tachypnea
Investigations
- Peak flow meter or spirometry, pulse oximetry
Treatment
- Avoid triggers and use inhaled corticosteroids to decrease underlying inflammation (for detailed information refer to O & G protocols and guidelines and MSTG respiratory conditions section).
- Antenatal clinics visit monthly if on regular medication.
- Avoid GERD in 3rd trimester by using Proton Pump Inhibitor or H2 blocker
- Peak flow meter EVERY 12HRS (first thing in the morning and 12 hrs later) if available
- For mild - moderate persistent asthma: salbutamol inhaler 1-2 puffs EVERY 8HRS or corticosteroid inhaler (i.e., beclomethasone)
- For acute and/or severe exacerbations:
- Admit to HDU
- O2 therapy to keep SaO2 >95%
- inhaled bronchodilator (salbutamol, ipromium bromide and normal saline) through a nebulizer or spacer every 10-20 min until improvement seen
- IV fluids
- IV Aminophylline 250 mg over 10 min or MGSo4 2g stat
- Sit up
- 4-hourly fetal monitoring
- Systemic steroids (i.e. hydrocortisone or prednisone IV) for up to 5-7 days
- Continuously assess response to treatment, complete response is resolution of symptoms and PEFR>80%
- Incomplete response is continuation of symptoms PEFR<80% personal best
- Urgent intervention required when PEFR <50% personal best
- Indication for intubation and ventilation: inability to maintain respiratory drive, worsening hypercapnia, respiratory acidosis, confusion and inability to maintain SpO2> 95% despite high flow oxygen
Intrapartum management
- Refer if at the health centre
- continue regular inhaler prn
- Use of IV hydrocortisone if patient has been on oral steroids >7.5mg/day for >2 weeks
- 4-hourly fetal monitoring
- Misoprostol if indication for labour induction
- Oxytocin if PPH
- Avoid use of PGF2 and Ergometrine
Check doses against the printed guideline and your clinical judgement before treating a patient. Spotted an error? Report it from the contact links below.
Need this without data?
The app holds every guideline on your device, with calculators, bookmarks and notes.